Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
Vittorio Maglione(University of Alberta), Simonetta Sipione(University of Alberta)
Cited by 142
Related Papers
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
|Scientific Reports|2017|78
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
|Frontiers in Neuroscience|2018|77